| Racial and Ethnic Disparities in Medication Adherence Among Privately Insured Patients in the United States Z Xie, PS Clair, DP Goldman, G Joyce PloS one 14 (2), 2019 | 101 | 2019 |
| Innovation in Heart Failure Treatment: Life Expectancy, Disability, and Health Disparities KE Van Nuys, Z Xie, B Tysinger, MA Hlatky, DP Goldman JACC: Heart Failure 6 (5), 401-409, 2018 | 47 | 2018 |
| Putting Stakeholder Engagement at the Center of Health Economic Modeling for Health Technology Assessment in the United States RZ Xie, EF Malik, MT Linthicum, JL Bright PharmacoEconomics, 1-8, 2021 | 29 | 2021 |
| Extended-Release Formulation and Medication Adherence JA Romley, Z Xie, T Chiou, D Goldman, AL Peters Journal of General Internal Medicine 35 (1), 354-356, 2020 | 9 | 2020 |
| Preferences for Treatments for Major Depressive Disorder: Formative Qualitative Research Using the Patient Experience S DosReis, LM Bozzi, B Butler, RZ Xie, RH Chapman, J Bright, E Malik, ... The Patient-Patient-Centered Outcomes Research 16 (1), 57-66, 2023 | 4 | 2023 |
| Patient perspectives: an integral part of health technology assessment methodology J Spangler, T Huth, R Xie International Journal of Technology Assessment in Health Care 38 (1), e85, 2022 | 4 | 2022 |
| Should we pay for scientific knowledge spillovers? The underappreciated value of “failed” R&D efforts RZ Xie, A Towse, LP Garrison International Journal of Technology Assessment in Health Care 38 (1), e31, 2022 | 4 | 2022 |
| HTA75 Prioritized Attributes to Better Define and Measure Innovation in Health Technology Assessment: Findings from an Expert Roundtable R Xie, MY Cheng, J Bright, J Spangler, JL Krieger, M Graglia, R Chapman Value in Health 26 (6), S273, 2023 | 1 | 2023 |
| Real-world treatment modalities, health care resource utilization, and costs among commercially insured patients with newly diagnosed major depressive disorder in the United States LN Pizzicato, RZ Xie, Y Yang, M Grabner, RH Chapman Journal of Managed Care & Specialty Pharmacy 29 (6), 614-625, 2023 | 1 | 2023 |
| Advancing Methods to Measure and Reward Healthcare Innovation R Chapman, R Xie PharmacoEconomics, 1-3, 2024 | | 2024 |
| Patient-Informed Value Elements in Cost-Effectiveness Analyses of Major Depressive Disorder Treatment: A Literature Review and Synthesis JF Slejko, TJ Mattingly II, A Wilson, R Xie, RH Chapman, A Amill-Rosario Value in Health, 2024 | | 2024 |
| EE501 Estimating the Impact of Delayed Treatment for Major Depressive Disorder Using a Continuous-Time Patient-Level Simulation Model R Chapman, M Cheng, R Xie Value in Health 27 (6), S149, 2024 | | 2024 |
| PCR195 Developing a Framework to Capture Economic Impacts on Patients and Caregivers: Recommendations to Guide Patient-Centered Outcomes Research and Value Assessment E Malik, R Xie, J Bright, R Chapman, E Cope, M Edmunds Value in Health 26 (6), S348, 2023 | | 2023 |
| PCR113 Treatment Preferences Among Adults with Reduced Productivity Due to Depression A Amill-Rosario, JF Slejko, R Xie, R Chapman Value in Health 26 (6), S332, 2023 | | 2023 |
| EE248 Patient-Informed Value Elements for Economic Evaluation of Treatment for Major Depressive Disorder: A Systematic Review and Synthesis JF Slejko, TJ Mattingly, A Wilson, R Xie, R Chapman Value in Health 26 (6), S104, 2023 | | 2023 |
| EE133 Applying Stakeholder Engagement to Effectively Design User Interfaces for an Economic Model in Major Depressive Disorder MY Cheng, R Xie, E Malik, M Mersky, R Chapman Value in Health 26 (6), S83-S84, 2023 | | 2023 |
| P47 A Discrete Choice Experiment to Assess Patient-Informed Preferences for Major Depressive Disorder Treatment By Depression Severity A Amill-Rosario, PL Huang, R Xie, R Chapman, JF Slejko Value in Health 26 (6), S10, 2023 | | 2023 |
| Patient-Informed Value Elements for Economic Evaluation of Treatment for Major Depressive Disorder: A Systematic Review and Synthesis JF Slejko, TJ Mattingly, A Wilson, R Xie, R Chapman, S dosReis | | 2023 |
| Treatment goals for rheumatoid arthritis: patient engagement and goal collection Z Predmore, EK Chen, TW Concannon, S Schrandt, SJ Bartlett, ... Journal of Comparative Effectiveness Research 12 (5), e220097, 2023 | | 2023 |
| Addressing Health Inequity in Value Assessments: A New Role for HEOR? RZ Xie, S dosReis, S Kowal, LP Garrison Value & Outcomes Spotlight, 2022 | | 2022 |
Dana P GoldmanSol Price School of Public Policy, University of Southern California在 usc.edu 的电子邮件经过验证
